4RK-92057-98970
2 vaccinations
0 coded responses
3 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 846 / UT
- Registered
- 2022-01-17
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2022-01-14
Dose 1 — Pfizer-BioNTech
-
2022-01-17
Registered in v-safe
-
2022-01-17
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Itching · Headache · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationAdult check-in
-
2022-01-17
Report sent to call center — days 1–6 daily, dose 1Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-01-18
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Itching · Headache, Rash, not including the immediate area around the injection site · Be unable to work or attend schoolAdult check-in
- 2022-01-18
-
2022-01-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Nausea, Abdominal pain, Rash, not including the immediate area around the injection siteAdult check-in
-
2022-01-19
Call successfulParticipant prefers to complete VAERS report online
-
2022-02-04
Dose 2 — Pfizer-BioNTech
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-01-14 | Pfizer-BioNTech | No |
| 2 | 2022-02-04 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-17 | Successful 2022-01-19 |
Participant prefers to complete VAERS report online |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.